EGFR and neoplasm: For instance, the anti-epidermal growth factor receptor (EGFR) mAb cetuximab inhibits EGFR signalling, which can indirectly enhance the efficacy of DNA-damaging platinum drugs and improve their anti-tumour activity [61].